|
|
|
- 您 可 以 信 任 的 醫 學 圖 書 智 庫 |
|
新書介紹www.leaderbook.com.tw
Evidence-based Respiratory Medicine
Edited By: Peter Gibson, John Hunter Hospital, Newcastle, NSW, Australia
Pub Date 2006
+CDROM
First major evidence-based text in adult respiratory medicine
Comprehensive, authoritative summary of the best treatments for the major respiratory diseases
Compiled by specialists from the Cochrane Airways Management Group
Easy-to-use format, with key clinical implications summarised in each chapter
Kept up-to-date online
Compiled by specialists from the Cochrane Collaboration Airways Management Group, Evidence-based Respiratory Medicine is the first major evidence-based text in adult respiratory medicine.
Providing a comprehensive summary of the best treatments for the most important respiratory diseases, some of the world’s leading physicians review the evidence for a broad range of treatments using evidence-based principles. Essential information is presented in an easy-to-understand format, with the most important clinical implications summarised in each chapter.
Evidence-based Respiratory Medicine tackles the big clinical questions in diagnosis and treatment, presenting treatment options which take into account the individual patient’s needs.
Evidence-Based Series: Evidence-based Respiratory Medicine, part of the acclaimed series BMJ Evidence-based medicine textbooks that have revolutionised clinical medicine literature, comes with a fully searchable CD-ROM of the whole text. The text is kept up to date online.
--------------------------------------------------------------------------------
Contents
Part 1 Practising evidence-based respiratory medicine
1.1 Introduction
1.2 Diagnostic strategies
1.2.1 Presenting symptoms
1.2.2 Lung function testing
1.2.3 Chest radiographic and CT patterns
1.2.4 Diagnostic strategies in pulmonary embolism: an evidence-based approach
1.2.5 Screening for lung cancer
1.3 Therapeutics: general issues
1.3.1 Adherence and self-management
1.3.2 Corticosteroid-induced osteoporosis
1.3.3 Helping people to stop smoking
Part 2 Asthma
2.1 Acute exacerbations
2.2 Chronic therapy: beta-agonists – short-acting, long-acting beta2-agonists
2.3 Inhaled corticosteroids in the treatment of asthma
2.4 Anti-leukotrienes
2.5 Asthma education
2.6 Non-pharmacological and complementary interventions to manage asthma
2.7 Difficult asthma
2.8 Novel therapies in asthma: long-acting beta2-agonists/inhaled corticosteroids
Part 3 Chronic obstructive pulmonary disease
3.1 Chronic obstructive pulmonary disease – acute exacerbations
3.2 Anticholinergic bronchodilators in chronic obstructive pulmonary disease therapy
3.3 Inhaled corticosteroids in chronic obstructive pulmonary disease
3.4 Combination of inhaled corticosteroids and long-acting beta2-agonists in chronic obstructive pulmonary disease
3.5 Systemic corticosteroids in stable chronic obstructive pulmonary disease
3.6 Lung volume reduction
Part 4 Infection
4.1 Bronchitis and sinusitis
4.2 Community-acquired pneumonia
4.3 Pulmonary tuberculosis
4.4 Influenza: vaccination and treatment
4.5 Bronchiectasis
4.6 Adult cystic fibrosis
4.7 Antibiotics in chronic obstructive pulmonary disease, bronchiectasis and cystic fibrosis
Part 5 Respiratory failure/sleep disordered breathing
5.1 Respiratory rehabilitation
5.2 Non-invasive ventilation in acute respiratory failure
5.3 Non-invasive positive pressure ventilation in stable patients with chronic obstructive pulmonary disease. What is the evidence?
5.4 The treatment of the obstructive sleep apnoea–hypopnoea syndrome
5.5 Long-term oxygen therapy for chronic respiratory failure in chronic obstructive pulmonary disease
Part 6 Diffuse lung disease/pleural disease/thromboembolism
6.1 Diffuse lung disease
6.1.1 The treatment of cryptogenic fibrosing alveolitis
6.1.2 Evidence-based approach to treatment of sarcoidosis
6.1.3 Hypersensitivity pneumonitis
6.2 Pleural disease
6.3 Therapy of pulmonary thromboembolism: an evidence-based approach
6.4 Pulmonary hypertension
|
|
|
|
|
└ 返回上一頁
|
|
